CiloTax StentTM - summitMD.com

More documents

Recommendations

Info

Current Status • 15 patients enrolled - First patient: Feb 27, 2008 - Enrolment <strong>com</strong>plete: June 30, 2008 • Study results expected in early spring 2009
Page 1 and 2: CiloTax Stent TM Dual Drug-eluting
Page 3 and 4: Moving Forward Co-drug Eluting Sten
Page 5 and 6: A Potent Anti-platelet Agent Effect
Page 7 and 8: Anti-restenotic Effect DECLARE - Lo
Page 9 and 10: The Ideal Combination? Cilotax TM S
Page 11 and 12: Cilotax Stent TM Polymer & Drugs Po
Page 13 and 14: Safety and Efficacy of the Cilotax
Page 15 and 16: Animal Preparation • Juvenile swi
Page 17 and 18: Analysis • Angiography and IVUS:
Page 19 and 20: Results 3.0 18mm Cilotax BMS 4 week
Page 21 and 22: IVUS Analysis at Follow-Up (n=7) BM
Page 23 and 24: Results BMS (n=3) Cilotax stent (n=
Page 25 and 26: Results Inflammatory Response BMS (
Page 27 and 28: Clinical Study Efficacy and Safety
Page 29 and 30: Objectives • to assess safety and
Page 31: Study Endpoints • Statistics - a

CiloTax StentTM - summitMD.com

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?